Therapeutics
See the pages linked below.
Related pages
- ACE inhibitors in heart failure
- Alcohol and coronary heart disease
- Alpha blockers in hypertension
- Angioplasty and atherosclerotic renal artery stenosis
- Anti-hypertensive therapy and risk of type II diabetes
- Aspirin in atrial fibrillation
- Beta blockers in cardiac failure
- Beta-blockers in myocardial infarction
- Bypass grafting versus medical treatment in angina
- Evidence comparing CABG and coronary angioplasty
- Calcium channel blockers in myocardial infarction
- Captopril Prevention Project
- CAPRIE trial
- CURE trial
- Digoxin in heart failure - trial evidence
- Cholesterol-lowering therapy
- Heart Outcomes Prevention Evaluation Study
- HOPE study in diabetics
- IONA study (Impact Of Nicorandil in Angina)
- INSIGHT trial
- Hypertension Optimal Treatment study
- LIFE study
- N-BNP levels to guide heart failure treatment
- NORDIL study
- PARADIGM-HF - angiotensin receptor neprilysin inhibition (ARNI) versus enalapril in reduced ejection fraction heart failure (HFrEF)
- Prevention of thromboembolism in atrial fibrillation
- Primary prevention of stroke in atrial fibrillation
- Secondary prevention of stroke in atrial fibrillation
- RALES study
- SYST-EUR study
- Therapeutic trials in congestive heart failure
- Treating hypertension to prevent stroke
- Trials of therapeutic intervention in MI
- Trials related to ACE inhibitors in cardiac failure
- Trials with respect to treatment of hypercholesterolaemia
- Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Study
- Valsartan Anti-hypertensive Long-term Use Evaluation (VALUE)
- Prasugrel or ticagrelor in ACS (acute coronary syndrome) - comparative evidence
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (DAPA-HF)
- Bedtime versus morning ingestion of hypertension and cardiovascular (CV) risk
- COLchicine Cardiovascular Outcomes Trial (COLCOT) - Efficacy and Safety of low-dose colchicine after myocardial infarction
- The Blood Pressure Lowering Treatment Trialists' Collaboration meta-analysis - pharmacological blood pressure lowering for prevention of cardiovascular disease
- AUGUSTUS trial - antithrombotic therapy after acute coronary syndrome (ACS) or PCI (percutaneous intervention) in atrial fibrillation (AF)
- Low-dose triple-pill vs standard-care protocols for hypertension treatment in Nigeria
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.